BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23776246)

  • 1. Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2.
    Sprowl JA; Ciarimboli G; Lancaster CS; Giovinazzo H; Gibson AA; Du G; Janke LJ; Cavaletti G; Shields AF; Sparreboom A
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11199-204. PubMed ID: 23776246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity.
    Yi Y; Li L; Song F; Li P; Chen M; Ni S; Zhang H; Zhou H; Zeng S; Jiang H
    Toxicology; 2021 Jul; 459():152853. PubMed ID: 34252480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice.
    Huang KM; Leblanc AF; Uddin ME; Kim JY; Chen M; Eisenmann ED; Gibson AA; Li Y; Hong KW; DiGiacomo D; Xia SH; Alberti P; Chiorazzi A; Housley SN; Cope TC; Sprowl JA; Wang J; Loprinzi CL; Noonan A; Lustberg MB; Cavaletti G; Pabla N; Hu S; Sparreboom A
    J Clin Invest; 2020 Sep; 130(9):4601-4606. PubMed ID: 32484793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
    Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
    J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic cation transporters are determinants of oxaliplatin cytotoxicity.
    Zhang S; Lovejoy KS; Shima JE; Lagpacan LL; Shu Y; Lapuk A; Chen Y; Komori T; Gray JW; Chen X; Lippard SJ; Giacomini KM
    Cancer Res; 2006 Sep; 66(17):8847-57. PubMed ID: 16951202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice.
    Calls A; Torres-Espin A; Tormo M; Martínez-Escardó L; Bonet N; Casals F; Navarro X; Yuste VJ; Udina E; Bruna J
    Ann Clin Transl Neurol; 2022 Dec; 9(12):1985-1998. PubMed ID: 36369764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity.
    Filipski KK; Mathijssen RH; Mikkelsen TS; Schinkel AH; Sparreboom A
    Clin Pharmacol Ther; 2009 Oct; 86(4):396-402. PubMed ID: 19625999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells.
    Buß I; Hamacher A; Sarin N; Kassack MU; Kalayda GV
    Metallomics; 2018 Mar; 10(3):414-425. PubMed ID: 29417972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies.
    Toyama S; Shimoyama N; Ishida Y; Koyasu T; Szeto HH; Shimoyama M
    Anesthesiology; 2014 Feb; 120(2):459-73. PubMed ID: 24064792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum accumulation in oxaliplatin-induced peripheral neuropathy.
    Wei G; Gu Z; Gu J; Yu J; Huang X; Qin F; Li L; Ding R; Huo J
    J Peripher Nerv Syst; 2021 Mar; 26(1):35-42. PubMed ID: 33462873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
    Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase.
    Franke RM; Kosloske AM; Lancaster CS; Filipski KK; Hu C; Zolk O; Mathijssen RH; Sparreboom A
    Clin Cancer Res; 2010 Aug; 16(16):4198-206. PubMed ID: 20601443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).
    Burger H; Zoumaro-Djayoon A; Boersma AW; Helleman J; Berns EM; Mathijssen RH; Loos WJ; Wiemer EA
    Br J Pharmacol; 2010 Feb; 159(4):898-908. PubMed ID: 20067471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phosphotyrosine switch regulates organic cation transporters.
    Sprowl JA; Ong SS; Gibson AA; Hu S; Du G; Lin W; Li L; Bharill S; Ness RA; Stecula A; Offer SM; Diasio RB; Nies AT; Schwab M; Cavaletti G; Schlatter E; Ciarimboli G; Schellens JHM; Isacoff EY; Sali A; Chen T; Baker SD; Sparreboom A; Pabla N
    Nat Commun; 2016 Mar; 7():10880. PubMed ID: 26979622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach.
    Zanardelli M; Micheli L; Cinci L; Failli P; Ghelardini C; Di Cesare Mannelli L
    PLoS One; 2014; 9(7):e102758. PubMed ID: 25036594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy?
    Di Cesare Mannelli L; Zanardelli M; Failli P; Ghelardini C
    Free Radic Biol Med; 2013 Aug; 61():143-50. PubMed ID: 23548635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation.
    Nassini R; Gees M; Harrison S; De Siena G; Materazzi S; Moretto N; Failli P; Preti D; Marchetti N; Cavazzini A; Mancini F; Pedretti P; Nilius B; Patacchini R; Geppetti P
    Pain; 2011 Jul; 152(7):1621-1631. PubMed ID: 21481532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity.
    Nepal MR; Taheri H; Li Y; Talebi Z; Uddin ME; Jin Y; DiGiacomo DF; Gibson AA; Lustberg MB; Hu S; Sparreboom A
    Cancer Res Commun; 2022 Nov; 2(11):1334-1343. PubMed ID: 36506732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src family kinase inhibitor Saracatinib (AZD0530) impairs oxaliplatin uptake in colorectal cancer cells and blocks organic cation transporters.
    Morrow CJ; Ghattas M; Smith C; Bönisch H; Bryce RA; Hickinson DM; Green TP; Dive C
    Cancer Res; 2010 Jul; 70(14):5931-41. PubMed ID: 20551056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice.
    Ta LE; Bieber AJ; Carlton SM; Loprinzi CL; Low PA; Windebank AJ
    Mol Pain; 2010 Mar; 6():15. PubMed ID: 20205720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.